A link has been identified between oxidative stress, which has previously been linked to aging and neurodegeneration, and sleep. Oxidative stress activates neurons that control sleep function. The findings could help in the development of treatments for sleep disorders.
CLOCK gene disruptions may be a mechanism that underlies several forms of autism and other neurodevelopmental conditions.
Children who snore while they sleep have thinner gray matter in several areas of the frontal lobes. Significantly, the reduction in gray matter correlated with behavioral problems associated with sleep apnea. Some behavioral problems experienced include hyperactivity, increased aggression, and attention deficits.
Researchers discover the switch in the brain which helps promote sleep.
Study adds to a growing body of evidence that stress in the workplace, coupled with impaired sleep, increases the risk of cardiovascular disease and coronary mortality, especially in hypersensitive workers.
Researchers report dream dysfunctions and sleep disorders may be warning signs of neurodegenerative diseases up to 15 years before other symptoms appear.
MIT researchers have developed a new, non invasive method to help monitor sleep patterns. The device uses an advanced AI algorithm to analyze wireless signals around a person and translate the measurements into sleep stages. Researchers plan to use the technology to study how Parkinson's disease affects sleep.
Galanin expressing neurons are selectively active during rebound sleep. The expression of galanin increases after neuronal activity and sleep deprivation. The neuropeptide plays a critical role in sleep homeostasis.
Researchers have identified five different subtypes of the sleep disorder insomnia, including difficulty falling asleep and early morning awakening. The study reports insomnia subtypes may be identified by examining personality traits of sufferers.
Using new technology to turn inflammation on and off in mice, researchers discover inflammation may contribute to sleep disorders.
Researchers identified molecules that can modulate circadian rhythms by binding to the MT1 melatonin receptor in the hypothalamus.
People who suffer from REM sleep behavior disorder are at increased risk of developing Parkinson's disease and dementia as they age, a new study reports. Researchers report RBD causes a lack of dopamine in the brain, and this can contribute to the development of neurodegenerative diseases.